FDA Inspection 1217650 — LUPIN LIMITED

LUPIN LIMITED — FEI 3012681202

The FDA completed an inspection of LUPIN LIMITED on Mar 24, 2023 in Navi Mumbai. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 24, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Navi Mumbai (India)

Additional details

Postmarket Adverse Drug Experience (PADE)

Need the full FDA record for LUPIN LIMITED? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.